Walleye Capital Portfolio holdings
AUM
$10.8B
1-Year Return
8.39%
This Quarter Return
-0.38%
1 Year Return
+8.39%
3 Year Return
+34.69%
5 Year Return
+89.54%
10 Year Return
–
AUM
$152M
AUM Growth
+$49.1M
(+48%)
Cap. Flow
+$51.6M
Cap. Flow
% of AUM
34%
Top 10 Holdings %
Top 10 Hldgs %
14.52%
Holding
1,209
New
228
Increased
123
Reduced
83
Closed
228
Top Buys
| 1 |
NFINU
Netfin Acquisition Corp. Unit
NFINU
|
+$2.57M |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.48M |
| 3 |
Humana
HUM
|
+$2.16M |
| 4 |
Cigna
CI
|
+$2.13M |
| 5 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$2.13M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
+$1.69M |
| 2 |
JFKKU
8i Enterprises Acquisition Corp Unit
JFKKU
|
+$1.58M |
| 3 |
GIX.U
GigCapital2, Inc.
GIX.U
|
+$1.35M |
| 4 |
CHAC.U
Chardan Healthcare Acquisition Corp.
CHAC.U
|
+$1.27M |
| 5 |
Artisan Partners
APAM
|
+$1.24M |
Sector Composition
| 1 | Healthcare | 21.13% |
| 2 | Technology | 12.2% |
| 3 | Consumer Discretionary | 11.67% |
| 4 | Communication Services | 6.38% |
| 5 | Materials | 3.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Forum Energy Technologies
FET
$313M
| $65K | ﹤0.01% |
2,109
-1,416
| -40% | -$43.6K |
|
327
CRISPR Therapeutics
CRSP
$4.88B
| $64K | ﹤0.01% |
+1,555
| New | +$64K |
|
|
SAVE
328
DELISTED
Spirit Airlines, Inc.
SAVE
| $64K | ﹤0.01% |
+1,768
| New | +$64K |
|
329
Commault Systems
CVLT
$8.23B
| $63K | ﹤0.01% |
1,420
+1,100
| +344% | +$48.8K |
|
330
FibroGen
FGEN
$46.4M
| $63K | ﹤0.01% |
69
+55
| +393% | +$50.2K |
|
331
LSB Industries
LXU
$562M
| $63K | ﹤0.01% |
+15,930
| New | +$63K |
|
332
Viasat
VSAT
$4.14B
| $63K | ﹤0.01% |
830
+497
| +149% | +$37.7K |
|
|
SIX
333
DELISTED
Six Flags Entertainment Corp.
SIX
| $63K | ﹤0.01% |
+1,250
| New | +$63K |
|
|
SFUN
334
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
| $63K | ﹤0.01% |
+2,842
| New | +$63K |
|
335
SSR Mining
SSRM
$4.29B
| $62K | ﹤0.01% |
+4,276
| New | +$62K |
|
|
SRCI
336
DELISTED
SRC Energy Inc
SRCI
| $61K | ﹤0.01% |
13,000
+1,500
| +13% | +$7.04K |
|
337
Bristol-Myers Squibb
BMY
$96.1B
| $61K | ﹤0.01% |
1,200
+600
| +100% | +$30.5K |
|
338
BlackBerry
BB
$2.23B
| $60K | ﹤0.01% |
11,502
+1,102
| +11% | +$5.75K |
|
|
HZNP
339
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $60K | ﹤0.01% |
2,200
+1,100
| +100% | +$30K |
|
340
Target
TGT
$41.3B
| $59K | ﹤0.01% |
550
+300
| +120% | +$32.2K |
|
341
Community Health Systems
CYH
$420M
| $58K | ﹤0.01% |
+16,000
| New | +$58K |
|
|
CBB
342
DELISTED
Cincinnati Bell Inc.
CBB
| $57K | ﹤0.01% |
11,200
-12,402
| -53% | -$63.1K |
|
|
TTM
343
DELISTED
Tata Motors Limited
TTM
| $56K | ﹤0.01% |
+6,700
| New | +$56K |
|
344
Banco Bradesco
BBD
$33.1B
| $54K | ﹤0.01% |
+8,785
| New | +$54K |
|
345
PVH
PVH
$3.96B
| $54K | ﹤0.01% |
610
+570
| +1,425% | +$50.5K |
|
|
EGRX
346
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $54K | ﹤0.01% |
960
+516
| +116% | +$29K |
|
347
F5
FFIV
$18.7B
| $53K | ﹤0.01% |
380
+310
| +443% | +$43.2K |
|
348
Royal Gold
RGLD
$12.2B
| $53K | ﹤0.01% |
+430
| New | +$53K |
|
349
Lumen
LUMN
$5.78B
| $52K | ﹤0.01% |
4,200
+200
| +5% | +$2.48K |
|
350
Procter & Gamble
PG
$373B
| $52K | ﹤0.01% |
+416
| New | +$52K |
|